Erratum: New β-Lactam–β-lactamase inhibitor combinations (Clin Microbiol Rev, (2021) 34(1), e00115-20, 10.1128/CMR.00115-20)

Dafna Yahav*, Christian G. Giske, Alise Gramatniece, Henrietta Abodakpi, Vincent H. Tam, Leonard Leibovici

*Corresponding author for this work

Research output: Contribution to journalComment/debate

14 Scopus citations

Abstract

Volume 34, no. 1, e00115-20, 2021, https://doi.org/10.1128/CMR.00115-20. Page 12, Table 4, “IMI-REL” column entry corresponding to Klebsiella pneumoniae, carbapenem resistant, n = 295, Greece (212): “8.0b” should read “98.0b.” Page 12, Table 4, “IMI-REL” column entry corresponding to Klebsiella pneumoniae, carbapenem resistant, Average susceptibility: “8.0” should read “98.0.”.

Original languageEnglish
Article numbere00021-21
Pages (from-to)1
Number of pages1
JournalClinical Microbiology Reviews
Volume34
Issue number2
DOIs
StatePublished - Apr 2021

Fingerprint

Dive into the research topics of 'Erratum: New β-Lactam–β-lactamase inhibitor combinations (Clin Microbiol Rev, (2021) 34(1), e00115-20, 10.1128/CMR.00115-20)'. Together they form a unique fingerprint.

Cite this